Axsome Therapeutics (AXSM) had the highest return in 2022 by a large-cap US stock in the Pharmaceuticals Industry, returning 103.3%.
| ASSET | YEAR | % RETURN |
|---|---|---|
Axsome Therapeutics (AXSM) | 2022 | 103.35% |
Merck (MRK) | 2022 | 49.54% |
Eli Lilly and (LLY) | 2022 | 35.12% |
Novo Nordisk A-S (NVO) | 2022 | 25.29% |
Jazz Pharmaceuticals (JAZZ) | 2022 | 24.19% |
Bristol-Myers Squibb (BMY) | 2022 | 19.52% |
Takeda Pharmaceutical Co Ltd ADR (TAK) | 2022 | 19.02% |
Teva Pharma Industries Ltd ADR (TEVA) | 2022 | 13.29% |
Novartis AG ADR (NVS) | 2022 | 7.96% |
Johnson & Johnson (JNJ) | 2022 | 6.51% |
Royalty Pharma (RPRX) | 2022 | 0.36% |
Sanofi ADR (SNY) | 2022 | -0.68% |
Pfizer (PFE) | 2022 | -9.57% |
Viatris (VTRS) | 2022 | -14.73% |
GlaxoSmithKline PLC ADR (GSK) | 2022 | -16.79% |
Dr Reddy’s Laboratories Ltd ADR (RDY) | 2022 | -17.07% |
Zoetis (ZTS) | 2022 | -39.07% |
Elanco Animal Health (ELAN) | 2022 | -57.15% |
Large-cap stocks are treated as having a market cap of $10B+.